Pharmacokinetics of midazolam in Vietnamese subjects

Journal of Gastroenterology and Hepatology (Australia)

Volumn 11, Issue 12, 1996, Pages 1177-1180

  Balson, K R ^a   Morgan, D J ^b   Richmond, B H ^b   McAlindon, M E ^a   Elliott, S L ^a   Yeomans, N D ^a,c  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c WESTERN HOSPITAL   (Australia)

Author keywords

Caucasian; midazolam; pharmacokinetics; Vietnamese

Indexed keywords

MIDAZOLAM;

ADULT; ARTICLE; ASIAN; BODY WEIGHT; CAUCASIAN; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; ETHNOLOGY; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; RACE DIFFERENCE; VIET NAM;

EID: 0030455406     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.1996.tb01848.x     Document Type: Article

References (12)

1. Lin KM, Shen WW. Pharmacotherapy for South East Asian psychiatric patients. J. Nerv. Ment. Dis. 1991; 179: 346-50.
2. Ghoneim MM, Korttila K, Chiang CK et al. Diazepam effects and kinetics in Caucasians and Orientais. Clin. Pharmacol. Ther. 1981; 29: 749-56.
3. Lin KM, Lau JK, Smith R, Phillips P, Antal E, Poland R. Comparison of alprazolam plasma levels in normal Asian and Caucasian male volunteers. Psychopharmacology 1988; 96: 365-9.
4. Allonen H, Ziegler G, Klotz U. Midazolam kinetics. Clin. Pharmacol. Ther. 1981; 30: 653-61.
5. Gibaldi, M, Perrier D. Pharmacokinetics. New York: Marcel Dekker, 1982.
6. Morgan DJ, Bray KM. Lean body mass as a predictor of drug dosage. Clin. Pharmacokinet. 1994; 26: 292-307.
7. Armitage P, Berry G (eds). Statistical Methods in Medical Research, 2nd edn. Oxford: Blackwell Science, 1985.
8. Spatzenegger M, Jaeger W. Clinical importance of hepatic cytochrome P450 in drug metabolism. Drug Metab. Rev. 1995; 27: 397-417.
9. Moschitto LJ, Greenblatt DJ. Concentration-independent plasma protein binding of benzodiazepines. J. Pharm. Pharmacol. 1983; 35: 179-80.
10. Darmansjah I, Muchtar A. Dose-response variation among different populations. Clin. Pharmacol. Ther. 1992; 52: 449-52.
11. Dundee JW, Collier PS, Carlisle RJT, Harper KW. Prolonged midazolam elimination half life. Br. J. Clin. Pharmacol. 1986; 21: 425-9.
12. Wills RJ, Khoo KC, Soni PP, Patel LH. Increased volume of distribution prolongs midazolam half-life. Br. J. Clin. Pharmacol. 1990; 29: 269-72.